Work

A dose-escalation study of the quinoxaline antitumor agent R(+)XK469 (XK) in patients with refractory solid tumors

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.2021

Authors: E. Sprague, S. D. Undevia, F. Innocenti, J. Ramirez, L. K. House, H. L. Kindler, D. A. Singh, A. A. Desai, R. L. Schilsky, M. J. Ratain

Institution: University of Chicago

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2241933419

Cites:

Cited by: 2

Related to: 10